UCB - Equity Capital And Reserves

Stock Price
264.50
Daily Change
-3.30 -1.23%
Monthly
4.59%
Yearly
64.44%
Q2 Forecast
257.81

UCB reported EUR10.87B in Equity Capital and Reserves for its fiscal semester ending in December of 2025.





Equity Capital And Reserves Change Date
Alcon AG USD 22.03B 52M Dec/2025
Almirall EUR 1.49B 24.03M Dec/2025
Amarin USD 459.28M 387K Dec/2025
argenx SE USD 6.1B 597.47M Jun/2025
AstraZeneca USD 48.67B 2.78B Dec/2025
Bayer EUR 25.95B 3.75B Dec/2025
Galapagos EUR 3.24B 788.91M Dec/2025
Genmab DKK 5.85B 96M Dec/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
GRIFOLS EUR 5.29B 108.05M Dec/2025
Hikma Pharmaceutical USD 2.59B 42M Dec/2025
Lonza CHF 9.13B 513M Dec/2025
Merck EUR 28.59B 344M Dec/2025
Novartis USD 46.13B 1.38B Dec/2025
Orion EUR 1.28B 265.4M Dec/2025
Recordati EUR 1.93B 57.32M Sep/2025
Roche Holding CHF 33.8B 758M Dec/2025
Sanofi EUR 71.71B 1.55B Dec/2025
UCB EUR 10.87B 1.18B Dec/2025
Unibail Rodamco EUR 15.9B 559M Dec/2025